Status:
TERMINATED
QOL Assessment in Cancer Survivors Integrated Into Routine Clinical Care
Lead Sponsor:
Geisinger Clinic
Conditions:
Cancer
Eligibility:
All Genders
Brief Summary
This observational cohort study of patients who received cancer treatment (of any modality) in the last 18 months are evaluated by the use of a validated QOL tool (FACT-GP) and are evaluated via telep...
Eligibility Criteria
Inclusion
- Diagnosis of malignancy in the last 18 months, treated with curative intent
Exclusion
- Patients treated with palliative intent, metastatic disease at the time of diagnosis
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03835052
Start Date
October 1 2018
End Date
March 30 2020
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Medical Center
Danville, Pennsylvania, United States, 17822